AlzeCure presents positive preclinical efficacy data for the TrkA-NAM pain project
AlzeCure Pharma, a pharmaceutical company that develops a broad portfolio of drug candidates for diseases affecting the central nervous system,...
Read More
SUBSCRIBE
and receive all of the latest news via our weekly newsletter
"*" indicates required fields
TRENDING NEWS
Tethered Spinal Cord Syndrome (TSCS): Pathophysiology and clinical presentation with a focus on anaesthetic management
Staff Writer - 8 October 2024
28-29 November 2024, Joint Winter Meeting of the Scottish Society of Anaesthetists and the Association of Anaesthetists 2024; Inverness
Staff Writer - 24 September 2024
A rare intrathoracic vascular anomaly
Staff Writer - 17 September 2024
Central Medical Supplies appoints new Account Managers
Staff Writer - 9 September 2024
Precision pain management: Tailoring strategies to individual patient profiles
Staff Writer - 5 September 2024
Anaesthetic implications of Aarskog-Scott syndrome
Staff Writer - 3 September 2024